Sight Diagnostics

📍 Tel Aviv, Israel🗓 Founded 2011👥 163 employees💰 Last funded Apr 2020
Medical Device🌐 sightdx.com
Website LinkedIn
The faster we diagnose, the faster we can treat. At Sight Diagnostics, we aim to improve health through fast, accurate and convenient diagnostic testing. Sight’s latest analyzer, Sight OLO, performs a Complete Blood Count, the most commonly ordered blood test, in minutes, not hours. It’s compact: designed to be used by anyone, anywhere. Sight’s method, developed over a decade of research, represents a step-change in diagnostic technology. Our analyzers create a digital version of your blood, by capturing 1,000 highly detailed images of a finger prick sample, which is then interpreted by our proprietary algorithms. Sight’s first product was focused on detecting Malaria, used in 24 countries, and has delivered almost 1 million tests to date. At Sight, exceptional individuals work together to achieve extraordinary things. We have rapidly growing offices in London, New York, and Tel Aviv.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Australia
1
Singapore
1
Frequently asked questions
Who invested in Sight Diagnostics?
Sight Diagnostics has 2 investors on record on gritt.io and 2 late-stage investors.
When did Sight Diagnostics last raise funding?
The most recent investment in Sight Diagnostics recorded on gritt.io was in April 2020.
When was Sight Diagnostics founded?
Sight Diagnostics was founded in 2011.
What industry is Sight Diagnostics in?
Sight Diagnostics operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Sight Diagnostics based?
Sight Diagnostics is headquartered in Tel Aviv, Israel.